• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Concord Biotech Limited — Board Meeting, 31-07-2026: Outcome of Board Meeting

    31-07-2026 | 06:18 pm

    Concord Biotech's Board approved consolidated financial results for the quarter ended June 30, 2026. Revenue from operations hit ₹257.49 Cr, with Profit After Tax (PAT) at ₹57.70 Cr. EPS stood at ₹5.52.

    No comments yet. Be the first to comment!

    All announcements from Concord Biotech Limited